NIH: Office of Disease Prevention


ODP Early-Stage Investigator Lecture

Early-Stage Investigator Lecture

The Office of Disease Prevention's Early-Stage Investigator Lecture was developed to recognize early-career prevention scientists who have not competed successfully for a substantial NIH-supported research project, but who have already made substantial, outstanding research contributions to their respective fields and are poised to become future leaders in prevention research. The award winner is invited, with all travel expenses covered, to give a lecture at the NIH and is offered an opportunity for professional networking with NIH program directors and scientists.

2018 Lecture Winner

Jacob Bor, ScD., SM
Jacob Bor, Sc.D., S.M.
Assistant Professor and Peter T. Paul Career Development Professor in the Departments of Global Health and Epidemiology at Boston University School of Public Health

Lecture Title: The Promise and Pitfalls of HIV Treatment-as-Prevention: Quasi-Experimental Evidence from South Africa

Jacob Bor, Sc.D., S.M., is an Assistant Professor and Peter T. Paul Career Development Professor in the Departments of Global Health and Epidemiology at Boston University School of Public Health. His research applies the analytical tools of economics and data science to the study of population health, with a focus on HIV treatment and prevention in southern Africa. Current research interests include chronic disease management in low-resource settings; economic spillover effects of HIV treatment; decision-making in HIV-endemic risk environments; population health impacts of social policy; and causal inference in public health research. His work has been published in Science, The Lancet, PLOS Medicine, Epidemiology, and Health Affairs. Prior to his graduate training at Harvard School of Public Health, Dr. Bor worked with an HIV-prevention NGO in Botswana, Lesotho, and South Africa. He is a faculty affiliate of Boston University’s Global Development Policy Center and junior faculty fellow at its Hariri Institute for Computing and Computational Science & Engineering. He is a Senior Researcher at the Health Economics and Epidemiology Research Office and a visiting researcher at the Africa Health Research Institute, both in South Africa.

The lecture is free and open to the public, and attendees can join either in person or via NIH VideoCast. In-person attendance is strongly encouraged.

2018 Finalists

Colin G. Walsh, M.D., M.A. External Website Policy
Assistant Professor of Biomedical Informatics, Medicine, and Psychiatry
Vanderbilt University Medical Center

Annie-Laurie McRee, Dr.P.H. External Website Policy
Assistant Professor, Division of General Pediatrics and Adolescent Health
Deputy Director, Healthy Youth Development, Prevention Research Center
University of Minnesota

Katrina Champion, Ph.D. External Website Policy
Australia’s National Health and Medical Research Council Early Career Fellow/Visiting Scholar
University of New South Wales, Sydney and Northwestern University

Review and Selection Process

  • Stage 1: The ODP assembles review panels composed of NIH staff with relevant expertise (informed by the nominations received). These content-area-specific panels perform the initial review of the nomination packages.
  • Stage 2: ODP staff reviews the recommendations from the content-area-specific panels and makes recommendations to the ODP Director.
  • Stage 3: The ODP Director reviews the recommendations and selects the finalists and the winner(s).

Eligibility Criteria

At the time of the nomination due date (October 27, 2017), the candidate must have met the NIH’s definition of an early-stage investigator (ESI). This means the candidate:

  • Had completed a terminal research degree within the last 10 years.
  • Had not yet been awarded a substantial NIH-supported research grant.

Federal government employees, including fellows and contractors, were not eligible.

Nominees should have:

  • Innovative and significant research accomplishments in applied prevention research in people and in areas that are relevant to the ODP’s mission.
  • Evidence of highly collaborative research projects, especially those that bridge disciplines to offer new approaches and ways of thinking in disease prevention research.
  • A track record of career advancement and evidence of leadership roles.

Priority was given to nominees conducting applied prevention research on any of the following:

  • Ten most common causes of death in the United States:
    1. Tobacco
    2. Overweight/obesity
    3. Poor diet
    4. Physical inactivity
    5. Alcohol misuse
    6. Exposure to microbial agents and/or toxic agents
    7. Motor vehicle accidents
    8. Injury and violence
    9. Risky sexual behavior
    10. Substance abuse
  • Methods and measurement research
  • Health disparities
  • Disease screening